Loading…

Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa

Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples teste...

Full description

Saved in:
Bibliographic Details
Published in:Infectious Diseases in Obstetrics and Gynecology 2009, Vol.2009, p.111-116
Main Authors: Desruisseau, Andrew J., Schmidt-Grimminger, Delf, Welty, Edith
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3
cites cdi_FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3
container_end_page 116
container_issue
container_start_page 111
container_title Infectious Diseases in Obstetrics and Gynecology
container_volume 2009
creator Desruisseau, Andrew J.
Schmidt-Grimminger, Delf
Welty, Edith
description Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples tested (67.2%) had HPV subtypes detected. The most common high risk types encountered were: 45 (24.6%) and 58 (21.5%). HIV-positive women were more likely to test positive for any HPV (P=.014), have more than one HPV subtype (P=.003), and to test positive for the high risk subtypes (P=.007). Of those with high risk HPV, HIV-positive women were more likely to have Thin Prep abnormalities than HIV-negative women (P=.013). Conclusions. Oncogenic HPV subtypes 45 and 58 were more prevalent than those subtypes carried in the quadrivalent vaccine. Further studies are needed to assess whether the current vaccine will be effective in this region.
doi_str_mv 10.1155/2009/810596
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a67844d3cd8a42f98597c1d2c9bcf67f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A234055193</galeid><airiti_id>P20151113004_200912_201711010026_201711010026_111_116</airiti_id><doaj_id>oai_doaj_org_article_a67844d3cd8a42f98597c1d2c9bcf67f</doaj_id><sourcerecordid>A234055193</sourcerecordid><originalsourceid>FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3</originalsourceid><addsrcrecordid>eNqFks9v0zAUxyMEYmNw4o4iJoEEhD07_hFfkKpqo5Uq6AG2AwfrNbZbT0lcknRo_z1OM8bKhYMV5-Xj73v-5pskLwl8JITzMwqgzgoCXIlHyTEBVWSglHw87AXLJGPqKHnWddcAUIDgT5MjCkQoUOw4-XG-9cbWPlRhfZsGl86Wl6lv0tn8MluGzvf-xqbYmH3hi13jvnBh295XNr0KtW0GfIq1bUNoPqRXtuvTiWt9ic-TJw6rzr64e54k3y_Ov01n2eLr5_l0ssiQcyIyV5icg2U5SpQE4_zoFFBRGGYUWRnLAWjOKJYEHTfM4QrBsVwIx3PmbH6SzEddE_Bab1tfY3urA3q9L4R2rTHOW1ZWo5AFYyYvTYGMOlVwJUtiaKlWpRPSRa1Po9Z2t6qtKW3Tt1gdiB5-afxGr8ONpgUlUkIUeHsn0Iafu2iGrn1X2qrCxoZdp2XOgDIiSSRf_0Neh13bRKc0UYJLTjmN0OkIrTGO7xsXYtdykNSTaApEB1UeqTcPqI3Fqt90odr1PjTdIfh-BMs2dF1r3f3NCOghTXpIkx7TFOlXD824Z__EJwLvRmDjG4O__H_UFiOMvo25-nvbZdTjhJAcgO1PEDq0kIQAib9eHL5EMC6R_wbtaeHb</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>196575252</pqid></control><display><type>article</type><title>Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Desruisseau, Andrew J. ; Schmidt-Grimminger, Delf ; Welty, Edith</creator><contributor>Pérez-López, Faustino R.</contributor><creatorcontrib>Desruisseau, Andrew J. ; Schmidt-Grimminger, Delf ; Welty, Edith ; Pérez-López, Faustino R.</creatorcontrib><description>Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples tested (67.2%) had HPV subtypes detected. The most common high risk types encountered were: 45 (24.6%) and 58 (21.5%). HIV-positive women were more likely to test positive for any HPV (P=.014), have more than one HPV subtype (P=.003), and to test positive for the high risk subtypes (P=.007). Of those with high risk HPV, HIV-positive women were more likely to have Thin Prep abnormalities than HIV-negative women (P=.013). Conclusions. Oncogenic HPV subtypes 45 and 58 were more prevalent than those subtypes carried in the quadrivalent vaccine. Further studies are needed to assess whether the current vaccine will be effective in this region.</description><identifier>ISSN: 1064-7449</identifier><identifier>EISSN: 1098-0997</identifier><identifier>DOI: 10.1155/2009/810596</identifier><identifier>PMID: 20169094</identifier><identifier>CODEN: IDOGEX</identifier><language>eng</language><publisher>Egypt: Hindawi Limiteds</publisher><subject>Adolescent ; Adult ; Cameroon - epidemiology ; Care and treatment ; Case studies ; Cervical cancer ; Cervical Intraepithelial Neoplasia - pathology ; Cervical Intraepithelial Neoplasia - virology ; Cervix Mucus - virology ; Clinical Study ; Developing countries ; Development and progression ; Diagnosis ; Female ; Genotype ; HIV patients ; HIV Seronegativity ; HIV Seropositivity - complications ; HIV Seropositivity - epidemiology ; Human papillomavirus ; Humans ; LDCs ; Medical research ; Papillomaviridae - classification ; Papillomaviridae - genetics ; Papillomavirus infections ; Papillomavirus Infections - complications ; Papillomavirus Infections - epidemiology ; Polymerase Chain Reaction ; Prevention ; Prevention programs ; Risk Factors ; Studies ; Surveys and Questionnaires ; Uterine Cervical Neoplasms - pathology ; Uterine Cervical Neoplasms - virology ; Vaginal Smears ; Womens health</subject><ispartof>Infectious Diseases in Obstetrics and Gynecology, 2009, Vol.2009, p.111-116</ispartof><rights>Copyright © 2009</rights><rights>COPYRIGHT 2009 John Wiley &amp; Sons, Inc.</rights><rights>Copyright Hindawi Publishing Corporation Fourth Quarter 2009</rights><rights>Copyright © 2009 Andrew J. Desruisseau et al. 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3</citedby><cites>FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/196575252/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/196575252?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4021,25751,27921,27922,27923,37010,37011,44588,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20169094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Pérez-López, Faustino R.</contributor><creatorcontrib>Desruisseau, Andrew J.</creatorcontrib><creatorcontrib>Schmidt-Grimminger, Delf</creatorcontrib><creatorcontrib>Welty, Edith</creatorcontrib><title>Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa</title><title>Infectious Diseases in Obstetrics and Gynecology</title><addtitle>Infect Dis Obstet Gynecol</addtitle><description>Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples tested (67.2%) had HPV subtypes detected. The most common high risk types encountered were: 45 (24.6%) and 58 (21.5%). HIV-positive women were more likely to test positive for any HPV (P=.014), have more than one HPV subtype (P=.003), and to test positive for the high risk subtypes (P=.007). Of those with high risk HPV, HIV-positive women were more likely to have Thin Prep abnormalities than HIV-negative women (P=.013). Conclusions. Oncogenic HPV subtypes 45 and 58 were more prevalent than those subtypes carried in the quadrivalent vaccine. Further studies are needed to assess whether the current vaccine will be effective in this region.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Cameroon - epidemiology</subject><subject>Care and treatment</subject><subject>Case studies</subject><subject>Cervical cancer</subject><subject>Cervical Intraepithelial Neoplasia - pathology</subject><subject>Cervical Intraepithelial Neoplasia - virology</subject><subject>Cervix Mucus - virology</subject><subject>Clinical Study</subject><subject>Developing countries</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Genotype</subject><subject>HIV patients</subject><subject>HIV Seronegativity</subject><subject>HIV Seropositivity - complications</subject><subject>HIV Seropositivity - epidemiology</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>LDCs</subject><subject>Medical research</subject><subject>Papillomaviridae - classification</subject><subject>Papillomaviridae - genetics</subject><subject>Papillomavirus infections</subject><subject>Papillomavirus Infections - complications</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Polymerase Chain Reaction</subject><subject>Prevention</subject><subject>Prevention programs</subject><subject>Risk Factors</subject><subject>Studies</subject><subject>Surveys and Questionnaires</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Uterine Cervical Neoplasms - virology</subject><subject>Vaginal Smears</subject><subject>Womens health</subject><issn>1064-7449</issn><issn>1098-0997</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFks9v0zAUxyMEYmNw4o4iJoEEhD07_hFfkKpqo5Uq6AG2AwfrNbZbT0lcknRo_z1OM8bKhYMV5-Xj73v-5pskLwl8JITzMwqgzgoCXIlHyTEBVWSglHw87AXLJGPqKHnWddcAUIDgT5MjCkQoUOw4-XG-9cbWPlRhfZsGl86Wl6lv0tn8MluGzvf-xqbYmH3hi13jvnBh295XNr0KtW0GfIq1bUNoPqRXtuvTiWt9ic-TJw6rzr64e54k3y_Ov01n2eLr5_l0ssiQcyIyV5icg2U5SpQE4_zoFFBRGGYUWRnLAWjOKJYEHTfM4QrBsVwIx3PmbH6SzEddE_Bab1tfY3urA3q9L4R2rTHOW1ZWo5AFYyYvTYGMOlVwJUtiaKlWpRPSRa1Po9Z2t6qtKW3Tt1gdiB5-afxGr8ONpgUlUkIUeHsn0Iafu2iGrn1X2qrCxoZdp2XOgDIiSSRf_0Neh13bRKc0UYJLTjmN0OkIrTGO7xsXYtdykNSTaApEB1UeqTcPqI3Fqt90odr1PjTdIfh-BMs2dF1r3f3NCOghTXpIkx7TFOlXD824Z__EJwLvRmDjG4O__H_UFiOMvo25-nvbZdTjhJAcgO1PEDq0kIQAib9eHL5EMC6R_wbtaeHb</recordid><startdate>2009</startdate><enddate>2009</enddate><creator>Desruisseau, Andrew J.</creator><creator>Schmidt-Grimminger, Delf</creator><creator>Welty, Edith</creator><general>Hindawi Limiteds</general><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>188</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>2009</creationdate><title>Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa</title><author>Desruisseau, Andrew J. ; Schmidt-Grimminger, Delf ; Welty, Edith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Cameroon - epidemiology</topic><topic>Care and treatment</topic><topic>Case studies</topic><topic>Cervical cancer</topic><topic>Cervical Intraepithelial Neoplasia - pathology</topic><topic>Cervical Intraepithelial Neoplasia - virology</topic><topic>Cervix Mucus - virology</topic><topic>Clinical Study</topic><topic>Developing countries</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Genotype</topic><topic>HIV patients</topic><topic>HIV Seronegativity</topic><topic>HIV Seropositivity - complications</topic><topic>HIV Seropositivity - epidemiology</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>LDCs</topic><topic>Medical research</topic><topic>Papillomaviridae - classification</topic><topic>Papillomaviridae - genetics</topic><topic>Papillomavirus infections</topic><topic>Papillomavirus Infections - complications</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Polymerase Chain Reaction</topic><topic>Prevention</topic><topic>Prevention programs</topic><topic>Risk Factors</topic><topic>Studies</topic><topic>Surveys and Questionnaires</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Uterine Cervical Neoplasms - virology</topic><topic>Vaginal Smears</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Desruisseau, Andrew J.</creatorcontrib><creatorcontrib>Schmidt-Grimminger, Delf</creatorcontrib><creatorcontrib>Welty, Edith</creatorcontrib><collection>Airiti Library</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ: Directory of Open Access Journals</collection><jtitle>Infectious Diseases in Obstetrics and Gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Desruisseau, Andrew J.</au><au>Schmidt-Grimminger, Delf</au><au>Welty, Edith</au><au>Pérez-López, Faustino R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa</atitle><jtitle>Infectious Diseases in Obstetrics and Gynecology</jtitle><addtitle>Infect Dis Obstet Gynecol</addtitle><date>2009</date><risdate>2009</risdate><volume>2009</volume><spage>111</spage><epage>116</epage><pages>111-116</pages><issn>1064-7449</issn><eissn>1098-0997</eissn><coden>IDOGEX</coden><abstract>Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples tested (67.2%) had HPV subtypes detected. The most common high risk types encountered were: 45 (24.6%) and 58 (21.5%). HIV-positive women were more likely to test positive for any HPV (P=.014), have more than one HPV subtype (P=.003), and to test positive for the high risk subtypes (P=.007). Of those with high risk HPV, HIV-positive women were more likely to have Thin Prep abnormalities than HIV-negative women (P=.013). Conclusions. Oncogenic HPV subtypes 45 and 58 were more prevalent than those subtypes carried in the quadrivalent vaccine. Further studies are needed to assess whether the current vaccine will be effective in this region.</abstract><cop>Egypt</cop><pub>Hindawi Limiteds</pub><pmid>20169094</pmid><doi>10.1155/2009/810596</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1064-7449
ispartof Infectious Diseases in Obstetrics and Gynecology, 2009, Vol.2009, p.111-116
issn 1064-7449
1098-0997
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a67844d3cd8a42f98597c1d2c9bcf67f
source Publicly Available Content Database; Wiley Open Access; PubMed Central
subjects Adolescent
Adult
Cameroon - epidemiology
Care and treatment
Case studies
Cervical cancer
Cervical Intraepithelial Neoplasia - pathology
Cervical Intraepithelial Neoplasia - virology
Cervix Mucus - virology
Clinical Study
Developing countries
Development and progression
Diagnosis
Female
Genotype
HIV patients
HIV Seronegativity
HIV Seropositivity - complications
HIV Seropositivity - epidemiology
Human papillomavirus
Humans
LDCs
Medical research
Papillomaviridae - classification
Papillomaviridae - genetics
Papillomavirus infections
Papillomavirus Infections - complications
Papillomavirus Infections - epidemiology
Polymerase Chain Reaction
Prevention
Prevention programs
Risk Factors
Studies
Surveys and Questionnaires
Uterine Cervical Neoplasms - pathology
Uterine Cervical Neoplasms - virology
Vaginal Smears
Womens health
title Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A17%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiology%20of%20HPV%20in%20HIV-Positive%20and%20HIV-Negative%20Fertile%20Women%20in%20Cameroon,%20West%20Africa&rft.jtitle=Infectious%20Diseases%20in%20Obstetrics%20and%20Gynecology&rft.au=Desruisseau,%20Andrew%20J.&rft.date=2009&rft.volume=2009&rft.spage=111&rft.epage=116&rft.pages=111-116&rft.issn=1064-7449&rft.eissn=1098-0997&rft.coden=IDOGEX&rft_id=info:doi/10.1155/2009/810596&rft_dat=%3Cgale_doaj_%3EA234055193%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=196575252&rft_id=info:pmid/20169094&rft_galeid=A234055193&rft_airiti_id=P20151113004_200912_201711010026_201711010026_111_116&rfr_iscdi=true